These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18178706)

  • 1. Masked clozapine-induced cardiomyopathy.
    Pastor CA; Mehta M
    J Am Board Fam Med; 2008; 21(1):70-4. PubMed ID: 18178706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine.
    Bobb VT; Jarskog LF; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):539-43. PubMed ID: 21186975
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.
    Floreani J; Bastiampillai T
    Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiomyopathy associated with clozapine.
    Leo RJ; Kreeger JL; Kim KY
    Ann Pharmacother; 1996 Jun; 30(6):603-5. PubMed ID: 8792945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].
    Kamphuis H; Arends J; Timmerman L; van Marle J; Kappert J
    Tijdschr Psychiatr; 2010; 52(4):223-33. PubMed ID: 20503163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine re-exposure after dilated cardiomyopathy.
    Nederlof M; Benschop TW; de Vries Feyens CA; Heerdink ER
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28551597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
    Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
    Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
    Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the adverse effects of clozapine: focus on myocarditis.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
    Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced cardiomyopathy: a first case in Japan.
    Kikuchi Y; Ataka K; Yagisawa K; Omori Y; Shimizu K; Kanbayashi T; Shimizu T
    Schizophr Res; 2013 Nov; 150(2-3):586-7. PubMed ID: 24025697
    [No Abstract]   [Full Text] [Related]  

  • 17. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience.
    Murch S; Tran N; Liew D; Petrakis M; Prior D; Castle D
    Australas Psychiatry; 2013 Jun; 21(3):258-61. PubMed ID: 23439546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
    Alba P
    Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].
    Schulte PF
    Tijdschr Psychiatr; 2011; 53(3):193-4. PubMed ID: 21404176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.